Rodríguez et al., 2015 - Google Patents
The composition of the gut microbiota throughout life, with an emphasis on early lifeRodríguez et al., 2015
View PDF- Document ID
- 11131885782839643179
- Author
- Rodríguez J
- Murphy K
- Stanton C
- Ross R
- Kober O
- Juge N
- Avershina E
- Rudi K
- Narbad A
- Jenmalm M
- Marchesi J
- Collado M
- Publication year
- Publication venue
- Microbial ecology in health and disease
External Links
Snippet
The intestinal microbiota has become a relevant aspect of human health. Microbial colonization runs in parallel with immune system maturation and plays a role in intestinal physiology and regulation. Increasing evidence on early microbial contact suggest that …
- 241000736262 Microbiota 0 title abstract description 212
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rodríguez et al. | The composition of the gut microbiota throughout life, with an emphasis on early life | |
Milani et al. | The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota | |
Turroni et al. | The infant gut microbiome as a microbial organ influencing host well-being | |
Bunyavanich et al. | Food allergy and the microbiome: Current understandings and future directions | |
Tamburini et al. | The microbiome in early life: implications for health outcomes | |
Wang et al. | Core gut bacteria analysis of healthy mice | |
Laforest-Lapointe et al. | Patterns of early-life gut microbial colonization during human immune development: an ecological perspective | |
Koleva et al. | Microbial programming of health and disease starts during fetal life | |
Fujimura et al. | Role of the gut microbiota in defining human health | |
Masi et al. | The role of the preterm intestinal microbiome in sepsis and necrotising enterocolitis | |
Abrahamsson et al. | Gut microbiota and allergy: the importance of the pregnancy period | |
Gosalbes et al. | Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants | |
Li et al. | Early development of the gut microbiome and immune-mediated childhood disorders | |
Collado et al. | Microbial ecology and host-microbiota interactions during early life stages | |
Charbonneau et al. | A microbial perspective of human developmental biology | |
Arrieta et al. | The intestinal microbiome in early life: health and disease | |
Underwood et al. | Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut | |
Øyri et al. | Dysbiotic gut microbiome: A key element of Crohn's disease | |
Corona-Cervantes et al. | Human milk microbiota associated with early colonization of the neonatal gut in Mexican newborns | |
Ntemiri et al. | Glycomacropeptide sustains microbiota diversity and promotes specific taxa in an artificial colon model of elderly gut microbiota | |
O'Connor et al. | Gut microbiota in older subjects: variation, health consequences and dietary intervention prospects | |
Anania et al. | Probiotics function in preventing atopic dermatitis in children | |
Wallace et al. | The impact of early life gut colonization on metabolic and obesogenic outcomes: what have animal models shown us? | |
Wolf et al. | Gut microbiota and obesity | |
Tannock | Building robust assemblages of bacteria in the human gut in early life |